Pharmaceutical Dissolution Testing Teaching Module
-
Upload
graham-coleman -
Category
Documents
-
view
81 -
download
0
description
Transcript of Pharmaceutical Dissolution Testing Teaching Module
![Page 1: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/1.jpg)
Pharmaceutical Dissolution TestingTeaching Module
Bo Hu
Chemical Engineering @ UPRM
![Page 2: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/2.jpg)
Outline
• Introduction
• Dissolution procedure
• IVIVC
• Dissolution Analysis
• Applications
![Page 3: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/3.jpg)
![Page 4: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/4.jpg)
Activity of GI-tract
Dosage Forms• Storage
• Separation – depending on technological type
• Transport
• Processing
–disintegration
–dissolution
–decomposition
• Absorption of drugs
–many xenobiotics are absorbed by passive diffusion (lipophilicity, molecular weight)
• Resecretion of drugs to GI-Tract
![Page 5: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/5.jpg)
• Drug disintegration --- first order process
• Drug dissolution ---proportional to the concentration difference of the drug between the particle surface and the bulk solution
![Page 6: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/6.jpg)
Definition
• Dissolution testing is a critical formulation tool in the process of drug discovery that entails measuring the stability of the investigational product, achieving uniformity in production lots and determining its in vivo availability. Thus this method is useful in the pharmaceutical and biotechnology industry to formulate drug dosage forms and to develop quality control specifications for its manufacturing process.
![Page 7: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/7.jpg)
Dissolution Method Development
• Physical and chemical properties of the drug
• Determination of the dissolution apparatus
• Selection of the dissolution medium
• Determination key operating parameters
• Method optimization
• Validation of the methodology
![Page 8: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/8.jpg)
Physical and Chemical Properties
• Ionization constants (pKa)
• Solubility as a function of pH
• Solution stability as a function of pH
• Particle size
• Crystal form
• Common ion, ion strength, and buffer effects
![Page 9: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/9.jpg)
Apparatus USP
• Apparatus 1 (Rotating basket)
• Apparatus 2 (Paddle assembly)
• Apparatus 3 (Reciprocating cylinder)
• Apparatus 4 (Flow-through cell)
• Apparatus 5 (Paddle over disk)
• Apparatus 6 (Cylinder)
• Apparatus 7 (Reciprocating holder)
![Page 10: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/10.jpg)
![Page 11: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/11.jpg)
Key Operating Parameters
• Media– Volume– Temperature: 37 0.5ºC– Deareation
• Sinker evaluation• Analytical detection• Sampling time points and
specifications
![Page 12: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/12.jpg)
![Page 13: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/13.jpg)
Deaeration
• Heating of the medium, followed by filtration and drawing of a vacuum for a short of time
• Temperature filtration
• Sonication
• Helium sparging
![Page 14: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/14.jpg)
Analytical detection
• UV detection --- easy for automation and faster analysis
• HPLC --- recommended method
![Page 15: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/15.jpg)
Sampling time points
Time Points
IR products
• Test time : 30 to 60 minutes
Specifications
• Single point : NLT 85% in 15 minutes
• Dissolution profile : sampling at 5-, 10-or 15-minute intervals
![Page 16: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/16.jpg)
Extended-Release Products
Test time : at least 3 test times
• Early time point : 1-2 hours : potential dose dumping
• Intermediate time point : define the release profile
• Final time point : show complete release of the drug
![Page 17: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/17.jpg)
Optimization
• Re-evaluation and optimization should be done when human BA data are available.
![Page 18: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/18.jpg)
Validation
• Linearity
• Accuracy
• Precision
• Specificity
• Robustness / ruggedness
![Page 19: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/19.jpg)
Robustness
Parameters for medium used are• pH• Medium volume or flow rate• Rotation speed• Apparatus sample position• Sinkers• Media deaeration• Temperature• Filters• Column and mobile conditions (if analyzed with HPLC)
![Page 20: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/20.jpg)
Dissolution procedure:• Discriminating method• Sufficient ruggedness• Reproducible operation• Transferable• Assessment of the batch-to-batch quality of a
drug product • Assessment of the physical stability of the
formulation• Low variability in dissolution results
![Page 21: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/21.jpg)
Qualitative tool
• Biological availability (BA)
• Biological equivalency (BE) (and / or)– Biowaivers (waivers from additional in vivo
studies for immediate release solid oral dosage forms)
• Batch to batch consistency– Product characterization– Quality control (QC)
![Page 22: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/22.jpg)
Bioequivalent drug products
• Pharmaceutical equivalency: the rate and extent of adsorption do not show a significant difference when administered at the same molar dose of therapeutic moiety under similar experimental moiety under similar experimental conditions, either single dose or multiple.
![Page 23: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/23.jpg)
In vitro/in vivo correlation (IVIVC)
• The main objective of the IVIVC is to establish the dissolution test as a surrogate for BE studies, which may reduce the number of BE studies performed during the initial approval process as well as with certain scale-up and post approval changes.
![Page 24: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/24.jpg)
Definition of IVIVC
• Predicative mathematical model describing the relationship between an in vitro property of the dosage form and an in vivo response.
• A general term that refers to a relationship between a biological property produced by a dosage form and a physicochemical characteristic of the same dosage form.
• Facilitate drug development by reducing the in vivo studies
![Page 25: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/25.jpg)
In Vivo Drug Release May Depend on
• TECHNOLOGY OFDOSAGE FORM• dissolution rate
– robustness of rate controlling mechanism
• .....• ANATOMY & PHYSIOLOGY of THE
GASTROINTESTINAL TRACT• Geometry (pylorus)• Mechanics (peristalsis)• Chemistry (pH)• Biochemistry (enzymes)• .....
![Page 26: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/26.jpg)
Approaches to obtain IVIVC
• Look for appropriate mathematical model to describe the relationship between in vitro-in vivo dissolution.
• Choose different dissolution conditions to match in vivo dissolution profile
![Page 27: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/27.jpg)
• Non-quantitative
• Quantitative IVIVC• Single-point correlation• Point-to-point IVIVC
![Page 28: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/28.jpg)
Interpretation of IVIVC time profiles
• Extent --- profile vertically in terms of its final plateau
• Rate --- process as fast or slow in terms of its mean time
• Shape --- additional information about the profile in terms of the variance or another equivalent metric
![Page 29: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/29.jpg)
Quality control
100
11log50
5.0
1
22
n
ttt TR
nf
![Page 30: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/30.jpg)
Extended application
• Ordinary tablets and capsules
• Extended –release
• Delayed-release
• Transdermal
• Multivitamin
• Mineral
• Class Monographs for non-prescription drug combinations
![Page 31: Pharmaceutical Dissolution Testing Teaching Module](https://reader033.fdocuments.us/reader033/viewer/2022061616/56813578550346895d9cdcba/html5/thumbnails/31.jpg)
References
• Textbook: Pharmaceutical Dissolution Testing (Hardcover) by Jennifer J. Dressman (Editor), Johannes Kramer (Editor) Publisher: Informa Healthcare; 1 edition (July 8, 2005)
• Other References: Seubpong Kumpusiri, Patima Maneesatid, The dissolution procedure: development and validation, Pharmacopeial forum Vol.31(5), 26May 2006